European platforM to PromOte Wellbeing and HEalth in the Workplace (EMPOWER)

NCT04907604 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 729

Last updated 2021-07-07

No results posted yet for this study

Summary

EMPOWER is a multidisciplinary research and innovation effort aiming to developing, implementing, evaluating and disseminating the effectiveness and cost-effectiveness of a modular eHealth intervention platform to promote health and well-being, reduce psychological distress, prevent common mental health problems and reduce their impact in the workplace. In collaboration with stakeholders, we will adapt existing effective interventions focused on different components (awareness and stigma, workplace conditions and psychosocial factors, stress, common mental health symptoms, early detection, comorbidity, lifestyle, and return to work) to created a combined online modular platform feasible in various workplace settings by culturally and contextually adapting it. The intervention will be implemented through a stepped wedge cluster randomized trial directed to employees and employers of small and medium sized enterprises and public agencies from three European countries (Spain, Finland and Poland) and United Kingdom. Both qualitative and quantitative methods will be used in the evaluation of the individual health outcomes, cost-effectiveness (from a social, economical, employer and employees perspective), and implementation facilitators and barriers. Implementation strategies relevant to the uptake of the EMPOWER intervention will be identified, including a realistic appraisal of barriers to uptake as well as evidence-based solutions to these barriers. Through scaling-up pre-existing effective and cost-effective interventions, EMPOWER is aimed at addressing the overarching challenges from different perspectives, including individual level (e.g., addressing stigma, mental health, well-being and lifestyles, taking into account legal, cultural and gender issues) and organizational level. The main outcomes effort will help employees, employers and policymakers in decision processes of new legal and contractual framework at EU and national level covering the new economy landscape.

Conditions

Interventions

DEVICE

A multi-modal and integrative e-health platform aimed at promoting health and reducing the negative impact of mental problems in the workplace

It addresses six main domains: improving awareness of mental health problems and reducing stigma; reducing psychosocial risk factors in the workplace; improving wellbeing and reducing psychological symptoms; ensuring early detection of mental disorders; promoting healthy behaviours and lifestyles; and facilitating early return to work.

Sponsors & Collaborators

  • Universidad Autonoma de Madrid

    collaborator OTHER
  • Erasmus University Rotterdam

    collaborator OTHER
  • Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

    collaborator OTHER
  • University of York

    collaborator OTHER
  • Fondazione Adapt

    collaborator UNKNOWN
  • Schweizer Paraplegiker Forschung

    collaborator OTHER
  • Australian National University

    collaborator OTHER
  • City of Turku

    collaborator OTHER_GOV
  • Ómada Interactiva SLL

    collaborator UNKNOWN
  • Instytut Medycyny Pracy Imienia Prof. Dra Med. Jerzego Nofera W Lodzi

    collaborator UNKNOWN
  • University of Lodz

    collaborator UNKNOWN
  • Vrije Universiteit Brussel

    collaborator OTHER
  • Fundació Sant Joan de Déu

    lead OTHER

Principal Investigators

  • Beatriz Olaya · Parc Sanitari Sant Joan de Déu

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-12-31
Completion
2023-08-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04907604 on ClinicalTrials.gov